A meta-analysis of 88 studies involving a cohort of 369 patients with Behçet’s disease treated with anti-TNF agents revealed that 89% (233/262) of the patients with Behçet’s disease-associated uveitis experienced sustained remission following IFX therapy [35]. This evidence concerns the gene TNF and uveitis.